| ²é¿´: 774 | »Ø¸´: 3 | |||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||||
190824656ľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
΢Æ×Ç󻯺ÏÎï½á¹¹
|
||||
| CÆ×Êý¾Ý£¨CDCl3£©£º211.6, 170.2, 168.3, 140.7, 138.1, 131.7, 129.6, 129.2, 129.1, 127.1, 122.8, 86.9, 63.0, 56.3, 55.8, 51.9, 48.0, 43.7, 39.1, 35.7, 35.6, 34.6, 20.3, 18.9, 14.5, 11.9. |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡
ÒѾÓÐ3È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÉêÇë»Ø¸åÑÓÆÚÒ»¸öÔ£¬±à¼Í¬ÒâÁË¡£µ«ÏµÍ³ÉϵÄʱ¼äû±ä£¬¸ø±à¼ÓÖдÓʼþÁË£¬Ã»»Ø¸´
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧ˶318Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
081700»¯¹¤Ñ§Ë¶µ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖú΢Æ×²éѯ»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´
ÇóÖú΢Æ×²éѯ»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´
[ÇóÖú] ÇóÖú΢Æ×²éѯ»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´
΢Æ×ÇóÖú»¯ºÏÎï½á¹¹
ÒѾÓÐ3È˻ظ´
ÇóÖúÁ½¸ö»¯ºÏÎïµÄ΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ3È˻ظ´
ÇóÖúÒ»¸ö»¯ºÏÎïµÄ΢Æ×Êý¾Ý
ÒѾÓÐ4È˻ظ´
΢Æ×ÇóÖú»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´
ÇóÖú΢Æ×Ò»Ö¬ÈÜÐÔ»¯ºÏÎïµÄ½á¹¹
ÒѾÓÐ9È˻ظ´
ÇóÖúÒ»»¯ºÏÎï΢Æ×½á¹¹
ÒѾÓÐ3È˻ظ´
΢Æ×ÇóÖúÒ»»¯ºÏÎï½á¹¹
ÒѾÓÐ3È˻ظ´
Çó΢Æ×¼ìË÷»¯ºÏÎï½á¹¹
ÒѾÓÐ3È˻ظ´
ÇóÖúÒ»»¯ºÏÎï΢Æ×Êý¾Ý½á¹¹
ÒѾÓÐ3È˻ظ´
ÇóÖúͨ¹ý΢Æ×²éѯ»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´
Çó¸ßÊÖ½âºìÍâÆ×ͼ£¬»¯ºÏÎï½á¹¹ÓУ¬ÏëºÍÆ×ͼ¶ÔÓ¦ÉÏ
ÒѾÓÐ13È˻ظ´
[ÇóÖú]ÄÄλºÃÈËѧУ¿ÉÒÔʹÓÃ΢Æ×Êý¾Ý¿â£¬°ïÎÒ¼ìË÷¼¸¸ö»¯ºÏÎïµÄĸºË¡£Ð»Ð»£¡
ÒѾÓÐ4È˻ظ´
΢Æ×13C NMRÊý¾Ý¿â ²éδ֪»¯ºÏÎï½á¹¹
ÒѾÓÐ3È˻ظ´
ÇóÖú¡¡Î¢Æ×Êý¾Ý¿â £Ã£Î£Í£ÒÊý¾Ý²éδ֪»¯ºÏÎï½á¹¹
ÒѾÓÐ6È˻ظ´
wangkaibo123
ÈÙÓþ°æÖ÷ (Ö°Òµ×÷¼Ò)
kerry
-

ר¼Ò¾Ñé: +726 - PhEPI: 3
- Ó¦Öú: 1928 (½²Ê¦)
- ¹ó±ö: 0.598
- ½ð±Ò: 7869.1
- É¢½ð: 10156
- ºì»¨: 100
- Ìû×Ó: 3780
- ÔÚÏß: 1007.1Сʱ
- ³æºÅ: 2088618
- ×¢²á: 2012-10-26
- ÐÔ±ð: GG
- רҵ: ¿¹Ö×ÁöÒ©ÎïÒ©Àí
- ¹ÜϽ: ҩѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
190824656: ½ð±Ò+15 2013-06-28 17:26:25
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
190824656: ½ð±Ò+15 2013-06-28 17:26:25
|
°´´ÓСµ½´ó˳ÐòÊäÈ룬Êý×Ö¼äÓÃÓ¢Îİë½Ç¶ººÅ(,)·Ö¸ôÀýÈ磺 21.4,30.4,37.4,73.2,73.7,125.6,126.6,139.6,140.2,168.2 ÈܼÁÑ¡Ï Æ¥ÅäÈݲ (Êý×Ö¸ñʽ£¬¿É×ÔÐÐÉ趨) ÏàËÆ¶È£º %(ÏàËÆ¶È>=50%) ²éѯ½á¹û£º¹²²éµ½186¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼) 1 . (2S)-N-[(1R,3RS)-3-((3R)-4,4-Dimethyl-2-oxo-tetrahydro-furan-3-yloxy)-3-methoxy-1-phenyl-propyl]-2-(1,3-dioxo-1,3-dihydroisoindol-2-yl)-3-phenyl-propionamide C33H34N2O7 ÏàËÆ¶È:60% Tetrahedron 2012 68 2179-2188 Access to C-protected ¦Â-amino-aldehydes via transacetalization of 6-alcoxy tetrahydrooxazinones and use for pseudo-peptide synthesis Pavlo Shpak-Kraievskyi, Biaolin Yin, Arnaud Martel, Robert Dhal, Gilles Dujardin, Mathieu Y. Laurent Structure 13C NMR ̼Æ×Ä£Äâͼ 2 . (S)-methyl 2-(2-(2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanamido)acetamido)-acetate ÏàËÆ¶È:60% Archiv der Pharmazie 2012 345 393-400 Synthesis, Pharmacokinetics, and Pharmacodynamics Studies of Valsartan Peptide Derivatives Chun Wu, Yanpeng Hu, Qianbin Li, Limei He, Jun Chen, Zeneng Cheng, Yuanjian Li and Gaoyun Hu Structure 13C NMR ̼Æ×Ä£Äâͼ 3 . cytochalasin E ÏàËÆ¶È:57.6% Journal of Natural Products 2006 69(6) 871-875 10-Phenyl-[12]-cytochalasins Z7, Z8, and Z9 from the Marine-Derived Fungus Spicaria elegans Rui Liu, Qianqun Gu, Weiming Zhu, Chengbin Cui, Guotao Fan, Yuchun Fang, Tianjiao Zhu, and Hongbing Liu Structure 13C NMR ̼Æ×Ä£Äâͼ 4 . cytochalasin E ÏàËÆ¶È:57.6% Chemical & Pharmaceutical Bulletin 1989 37 2212-2213 Nuclear Magnetic Resonance Studies of Cytochalasin E and Its Decomposition Product Tetsuya KAJIMOTO,Yohko IMAMURA,Masami YAMASHITA,Kokichi TAKAHASHI,Motoo SHIBATA and Toshihiro NOHARA Structure 13C NMR ̼Æ×Ä£Äâͼ 5 . cytochalasin E ÏàËÆ¶È:57.6% Agricultural and Biological Chemistry 1989 53 1699-1701 Structure of Rosellichalasin, a New Metabolite Produced by Rosellinia necatrix Yasuo KIMURA, Hiromitsu NAKAJIMA, Takashi HAMASAKI Structure 13C NMR ̼Æ×Ä£Äâͼ 6 . cytochalasin N C30H37NO7 ÏàËÆ¶È:57.1% Journal of the Chemical Society, Perkin Transactions 1 1989 57-65 Metabolites of the higher fungi. Part 24. Cytochalasin N, O, P, Q, and R. New cytochalasins from the fungus Hypoxylon terricola Mill Raymond L. Edwards, Derek J. Maitland and Anthony J. S. Whalley Structure 13C NMR ̼Æ×Ä£Äâͼ 7 . ethyl ent-15¦Á-benzoyloxymethyl-16¦Â-hydroxybeyeran-19-oate C30H42O5 ÏàËÆ¶È:56.6% Bioorganic & Medicinal Chemistry 2009 17 1464-1473 Stereoselective synthesis of bioactive isosteviol derivatives as ¦Á-glucosidase inhibitors Ya Wu, Jing-Hua Yang, Gui-Fu Dai, Cong-Jun Liu, Guo-Qiang Tian, Wen-Yan Ma, Jing-Chao Tao Structure 13C NMR ̼Æ×Ä£Äâͼ 8 . (S)-N¦Á,N1,¦Â,¦Â-Tetramethyltryptophanyl-(S)-tert-leucyl-(2e)-N-methyl-4-amino-2-methylbut-2-enoic acid C27H40N4O4 ÏàËÆ¶È:56% Journal of Natural Products 2003 66 183-199 Synthesis and Antimitotic/Cytotoxic Activity of Hemiasterlin Analogues James A. Nieman, John E. Coleman, Debra J. Wallace, Edward Piers, Lynette Y. Lim, Michel Roberge, and Raymond J. Andersen Structure 13C NMR ̼Æ×Ä£Äâͼ 9 . ajugacumbine F C25H38O7 ÏàËÆ¶È:56% Chemical & Pharmaceutical Bulletin 1990 38 3167-3168 Two New neo-Clerodane Diterpenes in Ajuga decumbens Zhi-da MIN,Mizuo MIZUNO,Shi-qiang WANG,Munekazu IINUMA and Toshiyuki TANAKA Structure 13C NMR ̼Æ×Ä£Äâͼ 10 . 1,3-Dibutyl-3,3a,5,9b-tetrahydro-9b-hydroxy-5-methyl-3a-phenyl-1H-imidazo[4,5-c]quinoline-2,4-dione C25H31N3O3 ÏàËÆ¶È:56% Helvetica Chimica Acta 2009 92 689-708 Molecular Rearrangement of 9b-Hydroxy-1H-imidazo[4,5-c]quinoline-2,4-diones - A Convenient Pathway to Spiro-Linked Imidazolidine-Oxindole Derivatives Anton¨ªn Kl¨¢sek, Anton¨ªn Lyčka, Ivan Mikš¨ªk, Aleš Růička Structure 13C NMR ̼Æ×Ä£Äâͼ 11 . ajugaciliatin J C25H38O7 ÏàËÆ¶È:56% Journal of Natural Products 2011 84 1575-1583 Bioactive neo-Clerodane Diterpenoids from the Whole Plants of Ajuga ciliata Bunge Ping Guo,Yushan Li, Jing Xu, Cuizhou Liu,Yonggang Ma, and Yuanqiang Guo Structure 13C NMR ̼Æ×Ä£Äâͼ 12 . (2R)-N-[(1R,3RS)-3-((3R)-4,4-Dimethyl-2-oxo-tetrahydro-furan-3-yloxy)-3-methoxy-1-phenyl-propyl]-2-(1,3-dioxo-1,3-dihydroisoindol-2-yl)-3-phenyl-propionamide C33H34N2O7 ÏàËÆ¶È:56% Tetrahedron 2012 68 2179-2188 Access to C-protected ¦Â-amino-aldehydes via transacetalization of 6-alcoxy tetrahydrooxazinones and use for pseudo-peptide synthesis Pavlo Shpak-Kraievskyi, Biaolin Yin, Arnaud Martel, Robert Dhal, Gilles Dujardin, Mathieu Y. Laurent Structure 13C NMR ̼Æ×Ä£Äâͼ 13 . 2¦Â-(2-phenylethylamino)-5¦Á-androstane-3¦Á,17¦Â-diol C27H41NO2 ÏàËÆ¶È:56% Bioorganic & Medicinal Chemistry 2008 16 5062-5077 Chemical synthesis of 2¦Â-amino-5¦Á-androstane-3¦Á,17¦Â-diol N-derivatives and their antiproliferative effect on HL-60 human leukemia cells Dominic Thibeault, Jenny Roy, Patrick DeRoy, Donald Poirier Structure 13C NMR ̼Æ×Ä£Äâͼ 14 . UK-2B C27H30N2O9 ÏàËÆ¶È:56% The Journal of Antibiotics 1996 49 1226-1231 UK-2A, B, C and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 II. Structural Elucidation MUHAMMAD HANAFI, KOZO SHIBATA, MASASHI UEKI, MAKOTO TANIGUCHI Structure 13C NMR ̼Æ×Ä£Äâͼ 15 . 5-carboxamido-3-{N-[3-(4-cyano-4-phenylpiperidin-1-yl)propyl]carboxamido}-1,4-dihydro-2,6-dimethyl-4-(4-nitrophenyl)pyridine hydrochloride sesquihydrate C30H34N6O4 ÏàËÆ¶È:56% Journal of Medicinal Chemistry 1998 41 5320-5333 Design and Synthesis of Novel ¦Á1a Adrenoceptor-Selective Dihydropyridine Antagonists for the Treatment of Benign Prostatic Hyperplasia Dhanapalan Nagarathnam, John M. Wetzel, Shou Wu Miao, Mohammad R. Marzabadi, George Chiu, Wai C. Wong, Xingfang Hong, James Fang, Carlos Forray, Theresa A. Branchek, William E. Heydorn, Raymond S. L. Chang, Theodore Broten, Terry W. Schorn, and Charles Gl Structure 13C NMR ̼Æ×Ä£Äâͼ 16 . cis-N-tert-butyl-2-[3-(1-2-amino-3-phenylpropionamido)-2-oxo-5-phenyl-8-methyl-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]ethanoic acid amide ÏàËÆ¶È:56% Journal of Medicinal Chemistry 1994 37 3789-3811 5-Phenyl-3-ureidobenzazepin-2-ones as Cholecystokinin-B Receptor Antagonists John A. Lowe III, David L. Hageman, Susan E. Drozda, Stafford McLean, Dianne K. Bryce, Rosemary T. Crawford, Stevin Zorn, Jean Morrone, Jon Bordner Structure 13C NMR ̼Æ×Ä£Äâͼ 17 . trans-N-tert-butyl-2-[3-(1-2-amino-3-phenylpropionamido)-2-oxo-5-phenyl-8-methyl-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]ethanoic acid amide ÏàËÆ¶È:56% Journal of Medicinal Chemistry 1994 37 3789-3811 5-Phenyl-3-ureidobenzazepin-2-ones as Cholecystokinin-B Receptor Antagonists John A. Lowe III, David L. Hageman, Susan E. Drozda, Stafford McLean, Dianne K. Bryce, Rosemary T. Crawford, Stevin Zorn, Jean Morrone, Jon Bordner Structure 13C NMR ̼Æ×Ä£Äâͼ 18 . (S)-2-((S)-2-(N-((2'-(1H-Tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanamido)propanoic acid ÏàËÆ¶È:56% Archiv der Pharmazie 2012 345 393-400 Synthesis, Pharmacokinetics, and Pharmacodynamics Studies of Valsartan Peptide Derivatives Chun Wu, Yanpeng Hu, Qianbin Li, Limei He, Jun Chen, Zeneng Cheng, Yuanjian Li and Gaoyun Hu Structure 13C NMR ̼Æ×Ä£Äâͼ 19 . (R)-methyl 2-(2-((S)-2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanamido)acetamido)propanoate ÏàËÆ¶È:56% Archiv der Pharmazie 2012 345 393-400 Synthesis, Pharmacokinetics, and Pharmacodynamics Studies of Valsartan Peptide Derivatives Chun Wu, Yanpeng Hu, Qianbin Li, Limei He, Jun Chen, Zeneng Cheng, Yuanjian Li and Gaoyun Hu Structure 13C NMR ̼Æ×Ä£Äâͼ |

4Â¥2013-06-28 14:52:46
190824656
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1797.9
- ºì»¨: 1
- Ìû×Ó: 501
- ÔÚÏß: 155.2Сʱ
- ³æºÅ: 682514
- ×¢²á: 2008-12-26
- רҵ: Ò©Îﻯѧ
3Â¥2013-06-28 13:46:59













»Ø¸´´ËÂ¥